4 articles
Sigue estos pasos antes de lanzar productos de combinación de dispositivos médicos en la UE, incluida la aplicación del artículo 117 del MDR y la Guía de la EMA.
Read more
Explore the crucial role of dendritic cells in DC-based immunotherapies for cancer, autoimmune diseases, and preventing graft rejection here.
Read more
Natural Killer (NK) cells, as part of our innate immune system, are very effective in killing different types of cells, including tumor cells. Because of these properties, they become very interesting as ATMPs for immunotherapy. Curious about the potential of Natural Killer (NK) cells and NK-cell-based immunotherapy? Learn all about them here, including the benefits and challenges.
Read morePreparing your Medical Device Combination Products for EU Launch? Learn more on how to apply MDR Article 117 and the EMA Directive.
Read moreWe use cookies to enhance your experience
We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.
